Clinical Trial

Trial of an Exercise Intervention for Children With Haemophilia

Study acronym: DOLPHIN-II
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 30, 2024 (before its estimated June 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
"Being able to participate in games and activities with their friends" is one of the things that matters most to boys with haemophilia. At present, there is a lack of robust evidence to determine whether muscle strengthening exercise can improve or negatively affect outcomes for young children with haemophilia. With the help of boys with haemophilia, their parents and physiotherapists the investigators have developed an exercise programme designed to increase muscle strength. Using this intervention the investigators will undertake a single-blinded, two-arm pragmatic randomised controlled trial (RCT) of a 12-week intervention verses usual care of boys with haemophilia aged 6-12 years of age.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-05-30.
Trial Details
NCT Number NCT05895032
Lead Sponsor East Kent Hospitals University NHS Foundation Trust
Collaborators: Great Ormond Street Hospital for Children NHS Foundation Trust, University of Kent
Conditions Hemophilia, Child, Only, Musculoskeletal Diseases or Conditions
Enrollment 132 participants
Start Date 2021-05-06
Primary Completion 2025-06-30 (estimated)
Study Completion 2025-06-30 (estimated)
Updated on ClinicalTrials.gov 2024-08-30